Methotrexate and Mycophenolate Mofetil for UVEITIS
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Methotrexate and Mycophenolate Mofetil for UVEITIS is a clinical trial[1].
Key Facts
- Methotrexate and Mycophenolate Mofetil for UVEITIS is in the country of Australia[2].
- Methotrexate and Mycophenolate Mofetil for UVEITIS is in the country of India[3].
- Methotrexate and Mycophenolate Mofetil for UVEITIS is in the country of Mexico[4].
- Methotrexate and Mycophenolate Mofetil for UVEITIS is in the country of Saudi Arabia[5].
- Methotrexate and Mycophenolate Mofetil for UVEITIS is in the country of United States[6].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's instance of is recorded as clinical trial[7].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's start time is recorded as +2013-08-31T00:00:00Z[8].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's end time is recorded as +2018-02-21T00:00:00Z[9].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's sponsor is recorded as University of California, San Francisco[10].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's main subject is recorded as uveitis[11].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's number of participants is recorded as {'unit': '1', 'amount': '+216'}[12].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's title is recorded as First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial[13].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's short name is recorded as FAST[14].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+16'}[15].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's ClinicalTrials.gov ID is recorded as NCT01829295[16].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's research intervention is recorded as methotrexate[17].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's research intervention is recorded as mycophenolic acid[18].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's research intervention is recorded as antimetabolite[19].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's research intervention is recorded as prednisone[20].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's clinical trial phase is recorded as phase III clinical trial[21].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's research site is recorded as Northwestern University[22].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's research site is recorded as Aravind Eye Hospital[23].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's research site is recorded as King Khaled Eye Specialist Hospital[24].
- Methotrexate and Mycophenolate Mofetil for UVEITIS's study type is recorded as interventional study[25].